Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Stereotaxis's peak revenue was $54.1M in 2010. The peak quarterly revenue was $9.2M in 2024(q3).
Stereotaxis's revenue increased from $15.0b in 2005 to $28.1M currently. That's a 87.32% change in annual revenue.
| Fiscal year / year | Stereotaxis revenue |
|---|---|
| 2009 | $51.1M |
| 2010 | $54.1M |
| 2011 | $42.0M |
| 2012 | $46.6M |
| 2013 | $38.0M |
| 2014 | $35.0M |
| 2015 | $37.7M |
| 2016 | $32.2M |
| 2017 | $31.1M |
| 2018 | $29.3M |
| 2019 | $28.9M |
| 2020 | $26.6M |
| 2021 | $35.0M |
| 2022 | $28.1M |
How accurately did Stereotaxis' revenue projections match actual performance?
Stereotaxis saw the greatest revenue growth in 2006, when revenue increased by 180,859.67%.
Stereotaxis had the lowest revenue growth in 2007, when revenue changed by -100.0%.
| Year | Stereotaxis growth |
|---|---|
| 2009 | 27%↑ |
| 2010 | 6%↑ |
| 2011 | -22%↓ |
| 2012 | 11%↑ |
| 2013 | -18%↓ |
| 2014 | -8%↓ |
| 2015 | 8%↑ |
| 2016 | -15%↓ |
| 2017 | -3%↓ |
| 2018 | -6%↓ |
| 2019 | -2%↓ |
| 2020 | -8%↓ |
| 2021 | 32%↑ |
| 2022 | -20%↓ |
Do you work at Stereotaxis?
Is Stereotaxis transparent about its revenue structure?
| CEO | David Leo Fischel |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 130 |
| Date Founded | 1990 |
| Headquarters | Saint Louis, Missouri |
| Number of Locations | 3 |
| Revenue | $28.1M |
| Net Income | -$18,292,000 |
| Gross Proft | $18.5M (2022) |
| PE Ratio | -4.50 |
| Market Capitalization | $82.4M |
| Total Assets | $53,413,000 |
| Ticker | STXS |
Stereotaxis received early financing of $20.0M on 2003-01-10.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $20M | 01/2003 |
| Series Unknown | $16M | 01/2004 |
| Post Ipo Equity | $10M | 05/2012 |
| Post Ipo Equity | $24M | 09/2016 |
| Post Ipo Equity | $10M | 03/2018 |
| Post Ipo Equity | $25M | 08/2019 |
| Investors | Security type |
|---|---|
| Ascension Ventures | Series Unknown |
| Advantage Capital | Series Unknown |
| Alafi Capital | Series Unknown |
| Stifel Financial Corp. | Series Unknown |
| DFJ Portage Ventures | Series Unknown |
| AG EDWARDS & SONS LLC | Series Unknown |
| Opaleye Management | Post Ipo Equity |
| Redmile Group | Post Ipo Equity |
| Parkman Healthcare Partners LLC | Post Ipo Equity |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Solta | - | $144.5M | 200 | - |
| Infraredx | - | $4.5M | 50 | - |
| Viveve | - | $6.4M | 42 | - |
| Spectranetics | - | $270.8M | 960 | - |
| TransMedics | - | $441.5M | 110 | - |
| Aspect Medical Systems | - | - | 200 | - |
| Cambridge Heart | - | $2.2M | 26 | - |
| Neural Analytics | - | $4.7M | 125 | - |
| Perminova | - | $250,000 | 5 | - |
| Urologix | - | $21.0M | 50 | - |
Zippia gives an in-depth look into the details of Stereotaxis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Stereotaxis. The employee data is based on information from people who have self-reported their past or current employments at Stereotaxis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Stereotaxis. The data presented on this page does not represent the view of Stereotaxis and its employees or that of Zippia.
Stereotaxis may also be known as or be related to Stereotaxis, Stereotaxis Inc, Stereotaxis Inc. and Stereotaxis, Inc.